Loading, Please Wait...
Dublin, Oct. 09, 2019 (GLOBE NEWSWIRE) -- The "Asia-Pacific Self-Monitoring Blood Glucose Devices Market (2019-2024) Share, Scope, Revenue, Growth Forecast, Trends, Drivers, Challenges, Segmentation based on Product Type (Testing Strips, Glucometers, Others) End-User Type and Countries" report has been added to ResearchAndMarkets.com's offering.
The Asia-Pacific self-monitoring blood glucose devices market is expected to expand at a CAGR of 6.34% during the 2019-2024 period, owing to technological breakthroughs, rising obesity, and the increasing prevalence of diabetes.
Product Segment Insights
The testing strips segment is expected to hold the highest market share (81.64%) in 2019. Owing to the development of innovative testing strips, and a massive increase in the incidence of diabetes, this segment is expected to witness a high CAGR of 6.94% during the forecast period. The glucometers segment is expected to remain steady while generating 12% of the revenue in the Asia-Pacific market in 2019. Factors like the advantages of glucometers over regular monitoring methodologies and the production of a wide range of devices will drive this segment. However, variations in results due to external and physiological factors will lead to a comparatively low CAGR (4.95%) during the 2019-2024 period.
End-user Segment Insights
The shift of medical services to decentralized surroundings like patients' homes and the development of portable and user-friendly blood glucose monitoring devices will enable the home settings segment to expand at a CAGR of 6.82% during the 2019-2024 period. The hospital's sector will generate almost 7% of the total market revenue by 2019 and is anticipated to expand at a CAGR of 4.78% during the forecast period.
China and India account for half of the total diabetic population in the Asia-Pacific region. Advanced medical facilities, awareness programs, and cost-effective treatments to tackle diabetes will transform this region into the fastest-growing SMBG devices market in the world. China is expected to expand at a CAGR of 6.62% during the forecast period, while healthcare initiatives and government programs in India will enable the market in the country to expand at a CAGR of 6.46%.
Key Topics Covered
1. Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary
2. Asia-Pacific self-monitoring blood glucose devices market - overview
2.1 Market definitions
2.2 Market overview
2.2.1 Historical market revenue (USD Bn)
2.2.2 Forecasted market revenue (USD Bn)
2.2.3 Country-wise market revenue (USD Bn)
2.3 Market trends
2.4 Market drivers
2.5 Market challenges
2.6 Value chain analysis
2.7 Porter's five forces analysis
3. Asia-Pacific self-monitoring blood glucose devices market - based on products
3.1 Testing strips
4. Asia-Pacific self-monitoring blood glucose devices market - based on end users
5. India self-monitoring blood glucose devices market
6. China self-monitoring blood glucose devices market
6.5 Market observations based on products
7. Australia and New Zealand self-monitoring blood glucose devices market
7.5 Market observations based on products
7.6 Market observations based on end-users
8. Rest of Asia-Pacific self-monitoring blood glucose devices market
8.5 Market observations based on products
8.6 Market observations based on end-users
9. Competitive landscape
9.1.1 Company snapshot
9.1.3 Strategic initiatives
9.1.4 Countries present
9.1.5 Key people
9.2 Roche Holding
9.3 Abbott Laboratories
9.5 Terumo Medical
10.1 PESTEL analysis
10.2 Impact assessment
10.3 Future outlook
For more information about this report visit https://www.researchandmarkets.com/r/sxhcol
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900